PDE9-IN-1
CAS No. 2305087-92-5
PDE9-IN-1( —— )
Catalog No. M26362 CAS No. 2305087-92-5
PDE9-IN-1 is a potent, selective, and orally bioavailable Inhibitor of phosphodiesterase-9A (PDE9A)(IC50 of 8.7 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 90 | In Stock |
|
| 5MG | 82 | In Stock |
|
| 10MG | 132 | In Stock |
|
| 25MG | 235 | In Stock |
|
| 50MG | 336 | In Stock |
|
| 100MG | 486 | In Stock |
|
| 200MG | 687 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePDE9-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionPDE9-IN-1 is a potent, selective, and orally bioavailable Inhibitor of phosphodiesterase-9A (PDE9A)(IC50 of 8.7 nM).
-
DescriptionPDE9-IN-1 is a potent, selective, and orally bioavailable Inhibitor of phosphodiesterase-9A (PDE9A)(IC50 of 8.7 nM).(In Vivo):In the Unilateral common carotid artery occlusion (UCCAO) mouse model, PDE9-IN-1 (2.5-5.0 mg/kg; orally) significantly reduces the day 6 escape latency time, increases the frequency of platform area crossings, and recoveres learning and memory function. High dose group possibly improved the escape latency time of mice.
-
In VitroPDE9-IN-1 is excellent selectivity across PDE families.
-
In VivoPDE9-IN-1 (2.5 and 5.0 mg/kg; Oral administration; daily for 21 days) effectively recovers learning and memory function. Animal Model:Unilateral common carotid artery occlusion (UCCAO) mouse model Dosage:2.5 and 5.0 mg/kg Administration:Oral administration; daily for 21 days Result:Significantly reduced the day 6 escape latency time and increased the frequency of platform area crossings, and recovered learning and memory function. High dose group possibly improved the escape latency time of mice.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorNMDA receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2305087-92-5
-
Formula Weight362.409
-
Molecular FormulaC17H23FN6O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (275.94 mM)
-
SMILESC[C@@H](Nc1nc2n(ncc2c(=O)[nH]1)C1CCCC1)C(=O)N1CC[C@H](F)C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Lozovaya N, Gataullina S, et al. Selective suppression of excessive GluN2C expression rescues early epilepsy in a tuberous sclerosis murine model. Nat Commun. 2014 Aug 1;5:4563.
molnova catalog
related products
-
Hydroxocobalamin
Hydroxocobalamin (Standard) is the analytical standard of Hydroxocobalamin. This product is intended for research and analytical applications. Hydroxocobalamin (Vitamin B12a) is an injectable naturally occurring form of vitamin B12 with a favorable adverse effect profile, used as a dietary supplement in the treatment of vitamin B12 deficiency including pernicious anemia.
-
Cochinchinenin C
1,2,4,5-Tetrachloro-3,6-dimethoxybenzene is an active compound. 1,2,4,5-Tetrachloro-3,6-dimethoxybenzene can be used for the research of various biochemical studies.
-
10-Methoxygambogenic...
10-Methoxygambogenic acid is highly cytotoxic to HL-60, SMMC-7721 and BGC-83 cells.
Cart
sales@molnova.com